Bone Loss and the Aromatase Inhibitors

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6602691
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Erratum To: Guidance for the Prevention of Bone Loss and Fractures in Postmenopausal Women Treated With Aromatase Inhibitors for Breast Cancer: An ESCEO Position Paper

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2012English

Molecular Docking of Aromatase Inhibitors

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2011English

Effects of Steroidal and Nonsteroidal Aromatase Inhibitors on Markers of Bone Turnover in Healthy Postmenopausal Women

Breast Cancer Research
Cancer ResearchOncology
2007English

Aromatase and Its Inhibitors: New Biology and Clinical Perspectives

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
1999English

Aromatase Inhibitors: A Dose-Response Effect?

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
1999English

The Effect of Third-Generation Aromatase Inhibitors on Aromatase Avtivity in Visceral Adipose Tissue

Regulatory Mechanisms in Biosystems
2018English

Molecular Action and Clinical Relevance of Aromatase Inhibitors

Oncologist
Cancer ResearchMedicineOncology
1998English

Carryover Effects of Aromatase Inhibitors in Prevention

The Lancet
Medicine
2020English

Use of Aromatase Inhibitors in Breast Carcinoma

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy